日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

PTEN mutant non-small cell lung cancer require ATM to suppress pro-apoptotic signalling and evade radiotherapy

PTEN 突变型非小细胞肺癌需要 ATM 来抑制促凋亡信号并逃避放射治疗

Thomas Fischer, Oliver Hartmann #, Michaela Reissland #, Cristian Prieto-Garcia, Kevin Klann, Nikolett Pahor, Christina Schülein-Völk, Apoorva Baluapuri, Bülent Polat, Arya Abazari, Elena Gerhard-Hartmann, Hans-Georg Kopp, Frank Essmann, Mathias Rosenfeldt, Christian Münch, Michael Flentje, Markus E

BCL-2 and BOK regulate apoptosis by interaction of their C-terminal transmembrane domains

BCL-2 和 BOK 通过其 C 端跨膜结构域相互作用调节细胞凋亡

Tobias B Beigl, Alexander Paul, Thomas P Fellmeth, Dang Nguyen, Lynn Barber, Sandra Weller, Benjamin Schäfer, Bernhard F Gillissen, Walter E Aulitzky, Hans-Georg Kopp, Markus Rehm, David W Andrews, Kristyna Pluhackova, Frank Essmann

Indolyl-chalcone derivatives trigger apoptosis in cisplatin-resistant mesothelioma cells through aberrant tubulin polymerization and deregulation of microtubule-associated proteins

吲哚基查尔酮衍生物通过异常的微管蛋白聚合和微管相关蛋白的失调引发顺铂耐药间皮瘤细胞凋亡

Sophia Steinlein, Frank Essmann, Amanda Franceschini Ghilardi, Heike Horn, Julia Schüler, Angelika Hausser, Lijun Sun, German Ott, Claudia Kalla

The BCL-2 inhibitor ABT-199/venetoclax synergizes with proteasome inhibition via transactivation of the MCL-1 antagonist NOXA

BCL-2 抑制剂 ABT-199/venetoclax 通过 MCL-1 拮抗剂 NOXA 的转录激活与蛋白酶体抑制产生协同作用

Sandra Weller, Astrid Toennießen, Benjamin Schaefer, Tobias Beigl, Alina Muenchow, Kathrin Böpple, Ute Hofmann, Bernhard F Gillissen, Walter E Aulitzky, Hans-Georg Kopp #, Frank Essmann #

BH3-only protein expression determines hepatocellular carcinoma response to sorafenib-based treatment

BH3 蛋白表达决定肝细胞癌对索拉非尼治疗的反应

Stephanie Busche #, Katharina John #, Franziska Wandrer, Florian W R Vondran, Ulrich Lehmann, Heiner Wedemeyer, Frank Essmann, Klaus Schulze-Osthoff, Heike Bantel

Alectinib treatment improves photodynamic therapy in cancer cell lines of different origin

艾乐替尼治疗可改善不同来源癌细胞系的光动力疗法

Bernhard Gillissen, Antje Richter, Frank Essmann, Wolfgang Kemmner

The BCL-2 selective inhibitor ABT-199 sensitizes soft tissue sarcomas to proteasome inhibition by a concerted mechanism requiring BAX and NOXA

BCL-2 选择性抑制剂 ABT-199 通过需要 BAX 和 NOXA 的协同机制增强软组织肉瘤对蛋白酶体抑制的敏感性

Alina Muenchow, Sandra Weller, Clemens Hinterleitner, Elke Malenke, Stefanie Bugl, Stefan Wirths, Martin R Müller, Klaus Schulze-Osthoff, Walter E Aulitzky, Hans-Georg Kopp #, Frank Essmann #

Threonine Phosphorylation of IκBζ Mediates Inhibition of Selective Proinflammatory Target Genes

IκBζ 的苏氨酸磷酸化介导选择性促炎靶基因的抑制

Paula Grondona, Philip Bucher, Anja Schmitt, Caroline Schönfeld, Barbara Streibl, Anne Müller, Frank Essmann, Sabrina Liberatori, Shabaz Mohammed, André Hennig, Daniela Kramer, Klaus Schulze-Osthoff, Stephan Hailfinger

Direct impact of cisplatin on mitochondria induces ROS production that dictates cell fate of ovarian cancer cells

顺铂对线粒体的直接影响会诱导 ROS 的产生,从而决定卵巢癌细胞的命运

Markus Kleih, Kathrin Böpple, Meng Dong, Andrea Gaißler, Simon Heine, Monilola A Olayioye, Walter E Aulitzky, Frank Essmann

Contribution of BH3-domain and Transmembrane-domain to the Activity and Interaction of the Pore-forming Bcl-2 Proteins Bok, Bak, and Bax

BH3 结构域和跨膜结构域对成孔 Bcl-2 蛋白 Bok、Bak 和 Bax 活性和相互作用的贡献

Daniel Stehle, Melanie Grimm, Stephanie Einsele-Scholz, Friederike Ladwig, Janina Johänning, Gerd Fischer, Bernhard Gillissen, Klaus Schulze-Osthoff, Frank Essmann